Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 3
1999 4
2000 5
2001 7
2002 3
2003 5
2004 10
2005 7
2006 9
2007 9
2008 14
2009 13
2010 12
2011 7
2012 19
2013 20
2014 13
2015 14
2016 17
2017 29
2018 27
2019 25
2020 19
2021 19
2022 27
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Among authors: laforet p. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
Update on new muscle glycogenosis.
Laforêt P, Malfatti E, Vissing J. Laforêt P, et al. Curr Opin Neurol. 2017 Oct;30(5):449-456. doi: 10.1097/WCO.0000000000000484. Curr Opin Neurol. 2017. PMID: 28737584 Review.
Cardiac Outcomes in Adults With Mitochondrial Diseases.
Savvatis K, Vissing CR, Klouvi L, Florian A, Rahman M, Béhin A, Fayssoil A, Masingue M, Stojkovic T, Bécane HM, Berber N, Mochel F, Duboc D, Fontaine B, Krett B, Stalens C, Lejeune J, Pitceathly RDS, Lopes L, Saadi M, Gossios T, Procaccio V, Spinazzi M, Tard C, De Groote P, Dhaenens CM, Douillard C, Echaniz-Laguna A, Quinlivan R, Hanna MG, Yilmaz A, Vissing J, Laforêt P, Elliott P, Wahbi K. Savvatis K, et al. Among authors: laforet p. J Am Coll Cardiol. 2022 Oct 11;80(15):1421-1430. doi: 10.1016/j.jacc.2022.08.716. J Am Coll Cardiol. 2022. PMID: 36202532 Free article.
Gene therapy review: Duchenne muscular dystrophy case study.
Berling E, Nicolle R, Laforêt P, Ronzitti G. Berling E, et al. Among authors: laforet p. Rev Neurol (Paris). 2023 Jan-Feb;179(1-2):90-105. doi: 10.1016/j.neurol.2022.11.005. Epub 2022 Dec 12. Rev Neurol (Paris). 2023. PMID: 36517287 Review.
Whole-body muscle MRI in McArdle disease.
Tobaly D, Laforêt P, Stojkovic T, Behin A, Petit FM, Barp A, Bello L, Carlier P, Carlier RY. Tobaly D, et al. Among authors: laforet p. Neuromuscul Disord. 2022 Jan;32(1):5-14. doi: 10.1016/j.nmd.2021.07.397. Epub 2021 Aug 5. Neuromuscul Disord. 2022. PMID: 34711478
Diaphragm: Pathophysiology and Ultrasound Imaging in Neuromuscular Disorders.
Fayssoil A, Behin A, Ogna A, Mompoint D, Amthor H, Clair B, Laforet P, Mansart A, Prigent H, Orlikowski D, Stojkovic T, Vinit S, Carlier R, Eymard B, Lofaso F, Annane D. Fayssoil A, et al. Among authors: laforet p. J Neuromuscul Dis. 2018;5(1):1-10. doi: 10.3233/JND-170276. J Neuromuscul Dis. 2018. PMID: 29278898 Free PMC article. Review.
[Pompe's disease].
Laforêt P. Laforêt P. Rev Med Interne. 2007 Dec;28 Suppl 4:S290-1. doi: 10.1016/j.revmed.2007.09.004. Epub 2007 Oct 5. Rev Med Interne. 2007. PMID: 18029059 French. No abstract available.
322 results